The Lancet Infectious Diseases
Издатель: Elsevier · ISSN 1473-3099 · 71 статей
- Who fills the silence in a crisis
- Between animals and humans
- Cross-neutralisation of authentic Ebola virus and Bundibugyo virus following natural infection or Ervebo vaccination
- Disruption of HIV services in Ukraine
- The inequality of adverse pregnancy outcomes related to Oropouche virus infections
- Oropouche virus infection in pregnant women in Rio de Janeiro, Brazil: a prospective cohort study
- Effectiveness of respiratory syncytial virus immunisation in practice
- Safety and immunogenicity of an adenoviral-vectored vaccine against Crimean–Congo haemorrhagic fever in the UK (CCHF01): an open-label, first-in-human, non-randomised, phase 1 clinical trial
- Dilemmas in the management of fluoroquinolone-resistant tuberculosis
- Hope for efficacious vaccines for Bundibugyo virus
- Can stochastic modelling predict cross-border spread of the Bundibugyo Ebola virus outbreak in Africa?
- Context matters: WHO-recommended tools in combinations validated for community tuberculosis screening
- HTLV-1: an overlooked sexually transmitted infection
- Nine-valent human papillomavirus vaccine: implications for cervical elimination
- Pragmatic tuberculosis trials must measure what determines implementation
- African countries' effort to interrupt polio outbreaks
- Increase of West Nile virus cases in Europe
- Momentum builds for the global elimination of trachoma
- The 17th annual NTD NGO Network conference
- Research in brief
- Vasee Moorthy
- Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study
- Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
- Community-based tuberculosis screening with computer-aided detection technology alone and in combination with point-of-care C-reactive protein testing: a paired screen-positive trial
- Community-engaged implementation strategies to increase doxycycline post-exposure prophylaxis uptake among men who have sex with men in China (DoxyForward): a three-group, open-label, randomised controlled trial
- Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study
- Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial
- Quantifying how multiple transmission routes contribute to the spread of HTLV-1 in different endemic foci: a mathematical modelling study
- Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial
- Guiding principles for pragmatic randomised trials of tuberculosis treatments